Status | Study |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors Condition: Adult Glioblastoma Endometrial Clear Cell Adenocarcinoma E Date: 2014-05-16 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis Condition: Noninvasive Mucinous Cystadenocarcinoma of Ovary Date: 2014-04-22 Interventions: Other: A sampling of blood A sampling of blood de 14 ml |
Recruiting |
Study Name: Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Tumor Date: 2014-04-07 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Date: 2014-03-28 Interventions: Drug: Gemcitabine Hydrochloride |
Terminated |
Study Name: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Condition: Mucinous Cystic Tumor With Moderate Dysplasia Mucinous Cystadenoma of Pancreas Date: 2012-02-01 Interventions: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr |
Withdrawn |
Study Name: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Condition: Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath Date: 2011-12-14 Interventions: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride |
Completed |
Study Name: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condition: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Date: 2011-02-10 Interventions: Drug: TLR8 Agonist VTX-2337 Gi |
Suspended |
Study Name: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condition: Nausea and Vomiting Ovarian Brenner Tumor Ovarian Clear Ce Date: 2011-01-11 Interventions: Procedure: Adjuvant Therapy An |
Terminated |
Study Name: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors Condition: Adenocarcinoma of the Pancreas Adenocarcinoma of the Stomach Date: 2010-11-02 Interventions: Drug: veliparib Given PO |